Researchers in China have used the body’s own immune system to kill cancerous cells in a pioneering new therapy.

EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.

The study conducted by IIT Roorkee is supported by the Indian Council of Medical Research (ICMR). It has been published in a ...

After a few dogged journalists, a small nonprofit pursuing Freedom of Information requests and an independent group of ...

More and more evidence points to the Wuhan lab as the origin of COVID-19, but answers are elusive, and a look at the issue ...

NY resident Sebastien Beauzile was treated with a pioneering new gene therapy approach called Lyfgenia, curing his sickle ...

New research into how a retrovirus is spreading across populations of wild koalas in Queensland, Australia is leading to a ...

Shares of LianBio (NASDAQ:LIAN – Get Free Report) traded down 2.1% during mid-day trading on Friday . The company traded as low as $0.20 and last traded at $0.20. 14,001 shares were traded during ...

Researchers devised a process to convert a skin cell directly into a neuron, eliminating the need to generate induced pluripotent stem cells. Such neurons could be used to treat spinal cord injuries ...

The recommendations were made following a meeting that included experts from the FDA, the Centers for Disease Control and Prevention, and the Department of Defense.

In a ceremony held last month, the 2024 Louisa Gross Horwitz Prize was awarded to Wesley Sundquist, PhD, Leo T. and Barbara K ...

CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...